drugset / Trial / NCT00199095

Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia

NCT00199095 ↗

Phase 4 Completed 40 enrolled Goethe University
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The aim of this study is to test feasibility and efficacy of a dose reduced chemotherapy in elderly patients with newly diagnosed acute lymphoblastic leukemia. The regimen consists of induction phase I and II followed by cyclic consolidation cycles, reinduction and maintenance therapy

Timeline

Start
1997-02
Primary completion
2003-06
Completion
2003-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclophosphamide Other / unclassified — —
Subject Cytarabine Small molecule — —
Subject Dexamethasone Small molecule — —
Subject Doxorubicin Other / unclassified — —
Subject Idarubicin Small molecule — —
Subject Ifosfamide Small molecule — —
Subject MERCAPTOPURINE ANHYDROUS Small molecule — —
Subject Methotrexate Small molecule — —
Subject Teniposide Small molecule — —
Subject Vincristine Small molecule — —